The high cost of bioanalytical testing has given the impetus to the outsourcing of analytical testing than in-house R&D; this has become a driving force for the market growth. The other factors that are adding numbers to the market growth are the increasing number of test techniques for better and accurate evaluation of the molecules orcompounds. To get the accuracy in the drug development and validation, strict regulations are imposed by regulatory authorities that have raised the trend of outsourcing analytical testing upwards. Pertaining to this, understanding of regulation has become one of the most critical aspect of drug development and validation. However, the lack of skilled professionals in the field of bioanalytical, high rate of attrition, ambiguity in regulatory are some restraining reasons in the market growth.
In this regard, CPhI Conferences is pleased to announce the 2nd edition of Biolytica scheduled on 3rd - 4th June 2021 as a virtual conference. This forum will focus on the new opportunities and gaps related to characterization, validation, regulation, technological advancement in the bioanalytical domain.